We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

DYNEX

Designs and manufactures fully-automated ELISA microplate workstations, laboratory instruments and associated consuma... read more Featured Products: More products

Download Mobile App





Dynex Demonstrates Automated, High Throughput Agility ELISA System at AACC 2021

By LabMedica International staff writers
Posted on 28 Sep 2021
Print article
Image: DYNEX Agility® (Photo courtesy of Dynex Technologies)
Image: DYNEX Agility® (Photo courtesy of Dynex Technologies)

Dynex Technologies (Chantilly, VA, USA) demonstrated its automated, high throughput Agility ELISA system at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

The event held at the Georgia World Congress Center in Atlanta, September 26-30 showcased the cutting-edge science and technology shaping the future of laboratory medicine.

Dynex is a leading designer and manufacturer of fully automated ELISA microplate workstations, laboratory instruments and associated consumables and accessories. From industry leading DSX and DS2 systems to the revolutionary Agility with SmartKit technology, Dynex is the leader in ELISA automation.

At AACC 2021, Dynex demonstrated its Agility fully integrated automated ELISA system that delivers high throughput with continuous plate loading flexibility for routine microplate testing. The fully automated platform allows users to optimize ELISA more than ever before, using electronic processing that provides premium precision with minimal manual operation. The technology relies on three precision robotic arms to accomplish the necessary tasks of sample pipetting, reagent pipetting and plates transporting.

The DYNEX AGILITY utilizes the proven versatility of ELISA’s core technology in a powerful, fully automated platform, for true ELISA optimization. Advanced robotic processing delivers unparalleled precision while eliminating nearly all manual steps, so AGILITY is efficient and reliable – freeing labs and their staff to be as productive as possible, while significantly reducing their cost per test.

Advanced robotics and direct-load reagent capability using innovative SmartKits provides operational efficiency. Agility Software offers sample serial dilution programming and run-time dilution capability ideal for COVID-19 Ab neutralization assays and other titer type assays. Automated onboard synchronization of sample dispense, and programmable wash cycles, help deliver high quality results. Quantitative or qualitative assays, with percentage inhibition calculations, can be fully automated with ease.

Related Links:
Dynex Technologies

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Coagulation Analyzer
CS-2400

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.